Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
adult vaccines
Biotech
GSK to lay off 1,200 roles in Belgium under cost-saving program
Up to 1,217 GSK employees in Belgium are at risk of losing their jobs as the Big Pharma rolls out its global cost-saving plans.
James Waldron
Oct 14, 2026 6:37am
Moderna winds down 3 mRNA programs
Nov 20, 2025 4:10pm
HHS unveils $500M universal vaccine development initiative
May 1, 2025 2:55pm
HHS delivers stop work order to Atlanta biotech, pulls funding
Apr 16, 2025 11:02am
VC firm fights to end Dynavax's 'empire-building' strategy
Feb 19, 2025 2:22pm
GSK, Merck and Pfizer in Ab&B's sights as biotech files for IPO
Jan 23, 2025 8:01am
